/

Società

H.

Non verificato

H. Lundbeck A/S

Di cosa scriviamo

Ecologia/Salute ambientaleFarmaceuticaFitnessSaluteSanità

11 comunicati stampa

Guarda tutti i comunicati

19/04/2026

Salute

Fitness

Cronaca Rosa / Gossip

Cronaca Bianca

Medicina - Varie

Ecologia/Salute ambientale

Agricoltura

Lundbeck presents new data at AAN 2026 highlighting real-world changes in migraine-related cognitive symptoms after starting VYEPTI® (eptinezumab)

Fonte

H. Lundbeck A/S

Emittente

1.00

0

13/04/2026

Salute

Fitness

Fiere

Eventi

Medicina - Varie

Scienza

Ecologia/Salute ambientale

Agricoltura

Lundbeck to showcase new neurology data at the American Academy of Neurology Annual Meeting

Fonte

H. Lundbeck A/S

Emittente

1.00

0

16/03/2026

Salute

Fitness

Cronaca Rosa / Gossip

Cronaca Bianca

Medicina - Varie

Ecologia/Salute ambientale

Agricoltura

Lundbeck advances Parkinson's research with new Phase 1b data at AD/PD™ 2026

Fonte

H. Lundbeck A/S

Emittente

1.00

0

10/03/2026

Salute

Fitness

Medicina - Varie

Ecologia/Salute ambientale

Agricoltura

Lundbeck appoints Chief AI Officer

Fonte

H. Lundbeck A/S

Emittente

1.00

0

08/05/2025

Farmaceutica

Sanità

Lundbeck to share pipeline data and key insights into the progression of rare disease, Multiple System Atrophy, at International MSA Congress in Boston

Fonte

H. Lundbeck A/S

Emittente

1.00

0

06/05/2025

Farmaceutica

Information Technology

Telecomunicazioni

Sanità

Economia

Brevetti, marchi e copyright

Lundbeck joins forces with Danish Centre for AI Innovation to improve brain health by advancing drug discovery with Gefion AI supercomputer

Fonte

H. Lundbeck A/S

Emittente

1.00

0

04/04/2025

Farmaceutica

Sanità

Finanza

Biologia

Lundbeck to present positive pipeline data at American Academy of Neurology (AAN) Annual Meeting

Fonte

H. Lundbeck A/S

Emittente

1.00

0

31/03/2025

Farmaceutica

Sanità

Following a planned interim analysis in the PROCEED trial Lundbeck expands the dose finding to intravenous administration of Lu AG09222 in migraine prevention

Fonte

H. Lundbeck A/S

Emittente

1.00

0

26/03/2025

Farmaceutica

Sanità

Economia

Management

Organizzazione Aziendale

Lundbeck held its Annual General Meeting on 26 March 2025 at the company's registered office

Fonte

H. Lundbeck A/S

Emittente

1.00

0

13/03/2025

Farmaceutica

Sanità

Economia

Start-up

Biologia

Rxulti® (brexpiprazole) approved in the European Union for the treatment of schizophrenia in adolescents aged 13 years and older

Fonte

H. Lundbeck A/S

Emittente

1.00

0

Seguaci

0

Compatibilità

0